Rheumatoid Arthritis Clinical Trials in New York

Showing 1061-1080 of 1,972 trials

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

NCT03663400

This is a prospective cohort study enrolling ulcerative colitis patients who initiate tofacitinib therapy. Investigators will collect clinical data, blood and stool samples prior to initiation of tofacitinib and, at minimum, monthly after the start of therapy. They will collect tissue from colonoscopies prior to initiation of therapy and within 6 months on therapy. Clinical characteristics and response to treatment will then be associated with genotype, blood immune profiles, stool microbiota, and cellular and molecular profiles of the biopsies to generate a treatment response model. Using predictors identified in our model, we will then attempt to validate the model and findings with the OCTAVE (Pfizer), SPARC (CCF), and RISK (CCF) data.

Ulcerative Colitis

NYU Langone Health47 participantsStarted Dec 2018

New York, New York, United States

COMPLETED< 1 mile

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

NCT03342586

The purpose of this study is to test resting state functional Magnetic Resonance Imaging (rsfMRI) scans to see if rsfMRI scans are better than the standard task based fMRI scans at diagnosing or monitoring central nervous system lymphoma.

Central Nervous System Lymphoma

Memorial Sloan Kettering Cancer Center14 participantsStarted Nov 2017

New York, New York, United States

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Rheumatoid Arthritis Trials in Other Cities

PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

RELAXaHEAD for Headache Patients (Phase I)

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

Surgical Idiopathic Intracranial Hypertension Treatment Trial

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study

Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities.

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

HeartMate 3™ CE Mark Clinical Investigation Plan

Other Conditions in New York